Although an important index, the level of bone mineral density (BMD) does not completely describe fracture risk. Another bone structural parameter, the orientation of type I collagen, is known to add to risk determination, independently of BMD, ex vivo. We investigated the Haversian system of transiliac crest biopsies from postmenopausal women before and after treatment with parathyroid hormone (PTH). We used the birefringence of circularly polarized light and its underlying collagen arrangements by confocal and electron microscopy, in conjunction with the degree of calcification by high-resolution micro-X-ray. We found that PTH treatment increased the Haversian system area by 48.28±38.78%; decreased bright birefringence from 0.45±0.02 to 0.40±0.01 (scale zero to one, p=0.0005); increased the average percent area of osteons with alternating birefringence from 48.15±10.27 to 66.33±7.73 (p=0.034), decreased non-
significantly the semi-homogeneous birefringent osteons (8.36±10.63 vs. 5.41±9. 13, p=0.40) and birefringent bright (4.14±8.90 vs. 2.08±3.36, p=0.10) osteons. Further, lamellar thickness significantly increased from 3.78±0.11μm to 4.47±0.14μm (p=0.0002) for bright, and from 3.32±0.12μm to 3.70±0.12μm (p=0.045) for extinct, lamellae. This increased lamellar thickness altered the distribution of birefringence and therefore the distribution of collagen orientation in the tissue. With PTH treatment, a higher percent area of osteons at initial degree of calcification was observed, relative to intermediate-low degree of calcification (57.16±3.08 vs. 32 .90±3. 69, p=0 .04), the percentage of alternating osteons at initial stages of calcification increasing from
Introduction
The anabolic effect of human PTH in osteoporosis has been a major focus of interest since the 1970s. (1) (2) (3) (4) (5) (6) (7) (8) Intermittent use of PTH(1-34) (once daily for 18-24 months) decreases vertebral and non-vertebral fracture risk in patients (5, 9, 10) and improves bone microstructure and strength in animal models. (11) (12) (13) (14) (15) Further, PTH(1-34) administration has been found in animal models to facilitate bone repair after fracture (16) (17) (18) (19) (20) and spinal fusion. (21) The anabolic action of PTH on bone has been found to vary with respect to compact and cancellous compartments. Cancellous bone volume in iliac crest biopsies from subjects treated with PTH(1-34) does not consistently increase, (22, 23) while cortical volume, thickness and endocortical wall width do increase significantly in postmenopausal women on PTH . (23) (24) (25) Recent experiments suggest that PTH increases the number of mesenchymal stem cells and stimulates vascular endothelial growth factor. (26, 27) In addition, PTH has been found to act as a pro-differentiation and anti-apoptopic agent on osteoblasts by reducing osteocytic sclerostin and Dkk1. (28) (29) (30) Such inhibition would lead to a stimulation of Wnt and Bmp anabolic pathways, accounting for some of the skeletal changes. (31) (32) (33) (34) Since cortical bone forms 80% of the adult skeleton, (35) is a major contributor to bone strength, (36, 37) and is increased by PTH treatment, we asked whether the compact microstructure is similar or different in the comparison of before and after treatment. This investigation was guided by two observations. First, the increased thickness of cortical bone following PTH(1-34) treatment indicated that the osteons formed during treatment may increase the percentage of osteons at initial stages of calcification. We use the term "calcification" throughout this paper "with reference to a process which leads to the formation of a solid, stable, amorphous or crystalline inorganic phase in the context of intraand/or extra-cellular organic structure". (38) This first observation led us to investigate the degree of calcification of the osteon. Second, we drew upon a set of three biomechanical findings: 1] PTH treatment was found to be associated with a reduced incidence of fractures in osteoporotic patients, and improved bone micro-structure and strength in animal models; (5) (6) (7) (8) (9) (10) (11) 2] patients with femoral neck fracture showed, at the fracture site, an altered lamellar thickness, (39) which is indicative of altered distribution of collagen type I orientation; (40) (41) 3] fracture is delayed in human cortical microstructure ex vivo by a 1.5 to 2-fold amplification of elastic range and a 3-fold increase in stiffness by orientation of collagen type I. (42) This set of findings allows us to hypothesize that after treatment the bone tissue shows an altered distribution of collagen orientation and of degree of calcification. Since the molecular pathway by which Wnt and Bmp under PTH treatment affect the cortical micro-structural parameters mentioned here is unknown, the biomechanical motivation that underlies our hypothesis serves to identify a phenomenon that merits investigation from a molecular biology perspective.
The orientation of collagen and locally parallel carbonated hydroxyapatite within the lamellae are fundamental to rendering the mechanical properties of single osteons suitable to specific types of loading. (42) The study of cortical micro-structure can be dated back to Galileo, who first hypothesized the importance of bone micro-structure in determining macro-structural strength, (43) by virtue of provision of reinforcement in the preferential direction of the vascular canals. The study of osteons' lamellar components has involved numerous investigators since the first observation of lamellae by Leeuwenhoek in the late 1600's. (44) In health and in the presence of specific bone pathologies, collagen-apatite architecture has been found to adapt to local mechanical requirements and to show a heterogeneous non-random pattern throughout the macro-structure. (45) From a material science perspective, a material that shows reinforcements that vary in orientation and density in response to the local mechanical environment, with changeable orientation and intensity, delays occurrence of fracture more successfully than an isotropic homogenous material.
Material and Methods
This study uses bone biopsy material collected as part of an ongoing clinical trial designed to evaluate the effects of PTH(1-34) on bone structure and dynamic behavior, as well as the interaction of PTH(1-34) with antiresorptive agents such as bisphosphonates. (25) In 8 postmenopausal women with osteoporosis, transiliac crest bone biopsies were obtained before and after treatment with daily injections of 400 U of PTH(1-34) for 36 months. All subjects were on a chronic, stable dose of estrogen therapy throughout the duration of the study. Table 1 summarizes the age and previously reported cortical variables from the iliac crest bone biopsies obtained in that study and used in this investigation. Bone biopsies were embedded, cut, and prepared according to previously published methods. (46) The Haversian system of each of the two cortices per section, one section per biopsy, was investigated. We considered the osteons as secondary osteons because the usually smaller primary osteons were not found here. (47) We investigated, in this order, the degree of calcification by micro-X-ray and the birefringent signal of circularly polarized light (CPL), whose underlying collagen orientation was observed at higher resolution by scanning confocal microscopy (SCM), and scanning transmission electron microscopy (STEM). The observers were blind to whether each specimen was obtained before or after PTH(1-34) treatment.
High-resolution micro-X-radiography
This method was used to observe osteons formed during PTH(1-34) treatment and at various degrees of calcification at the maximum resolution available. We prepared the highresolution (from 1 to 1.5μm) micro-X-ray with a micro-focus microradiograph (Ital-Structures, Riva del Garda-Trento, Italy) and high resolution glass plates (Microchrome Technology, San Jose, California) according to published methods. (47) (48) (49) (50) In particular, an aluminum scale was micro-X-rayed with the bone section to provide a calibration for quantification of calcification.
Regular light and CPL microscopies
Each micro-X-ray ( Fig. 1 ) and corresponding section, after rehydration with distilled water on non-cover slipped slide, were observed with a Leitz Dialux 20 (Midland, Ontario, Canada) from 100 to 160x. We labeled an osteon "whole" if it included a Haversian canal, whether complete or not. We took partially overlapping images of the entire cortices by regular light (RL) and CPL at maximum light intensity and by RL on micro-X-rays at 160x. We imported the images in XaraX software (Xara Group Ltd, London, England) stacked in three virtual layers (RL, CPL of section and RL of micro-X-ray) and reconstructed the three layers of each cortex. On a separate virtual layer, we traced the outer boundary of the cortex and of each osteon at the cement line. On a second, separate virtual layer of the stack, to assess lamellar thickness we drew segments in triplicate at 500x, across each bright and extinct lamella of alternating osteons. We exported each of the three reconstructed images and each of the layers with tracing from XaraX at 300 dpi for good resolution.
We calibrated MetaMorph software (Molecular Devices, Sunnyvale, California, United States) to measure in real microns. We programmed Metamorph to 1] open five images per cortex (RL and CPL of section, RL of micro-X-ray, two images with osteon tracing and lamellar thickness tracing) and arrange them in a virtual stack; 2] measure the area of the cortex and of each osteon; 3] assess the percentage of osteons and of interstitial bone at specific stages of calcification on a scale from 0 to 1: initial stage (0 to 0.24), intermediatelow stage (0.25 to 0.49), intermediate-high stage (0.5 to 0.74) and final stage (0.75 to 1); 4] measure the cortical porosity as the total area of Haversian canals plus resorption spaces, expressed as a percentage of the total area of the cortex; and 5] calculate the average birefringent brightness of the Haversian system on each cortex with a built-in function, as the sum of the grey values divided by the number of pixels after calibrating on a scale from 0 to 1, with 0 being completely extinct and 1 brightest.
To confirm visual assessment and to assess heterogeneity of birefringence of individual whole ostens, we thresholded the CPL image within the top half of the grey scale from 0 to 1 to mean "bright". Metamorph colored in orange the bright regions, allowing us to classify and count osteons as "alternate" (alternating bright and extinct lamellae), "semihomogeneous" (containing bright or extinct regions that span portions of lamellae) and "bright" (completely bright). Because so-called "extinct" osteons always show a small 3 to 4% of bright lamellae around the Haversian canal, (42) they were denominated here as "semihomogeneous". We programmed Maple software to 1] measure the segments, previously drawn with XaraX software, representing lamellar thickness of alternate osteons and to assess the percentages of alternate osteons at specific stages of calcification by sorting alternate osteons by degree of calcification; and 2] sort the osteons by CPL appearance (alternate, semi-homogeneous, bright) and by degree of calcification (initial, intermediatelow, intermediate-high, final) and compute percentage for each combination of CPL appearance and degree of calcification.
Because in extinct field, the bright and extinct signals of birefringence are indicative of difference in organization of type I collagen, (40, 41) the collagen orientation ranges underlying each of the bright and extinct birefringent signals were investigated by SCM and STEM.
Scanning confocal microscopy (SCM)
After rehydration with distilled water, each section was observed by a TCS-SP microscope (Leica Microsystems GmbH) with a krypton laser (568 nm excitation), 20x and 63x Planapochromat lens, and 580 to 700 nm detection wavelength range. The endogenous fluorescence of collagen provided good contrast on an extinct background of glycosaminoglycans and glycoproteins. (41, 51) Light detected by photomultipliers was converted to pseudo-color for good visualization. Each section was scanned every 0.5μm to avoid either overlap or gaps between subsequent images. Stacks of images were collected automatically. We chose the same regions through the scanned image stack, covering 100μm x 100μm of the specimen in correspondence to regions of either brightness or extinction birefringence by CPL.
Collagen bundles appeared on the plane of focus as dots or segments, indicative of a range of orientations with respect to the direction perpendicular to the plane of the section. (41) A dot indicated collagen oriented longitudinally with respect to the transverse section observed by SCM, that is parallel to the Haversian canal direction. A segment was indicative of collagen not perpendicular to the transverse section. We distinguished dots from segments by identifying the dots as elements with width to length ratio up to 1.2; and the segments as elements with width to length ratio greater than 1.2. We marked the collagen bundles as dots and segments with XaraX software. We programmed Metamorph software to 1] measure with built-in functions width and length of the labeled elements in real microns; and 2] compute the percentage of dots and the percentage and length of segments. We conducted this analysis for bright and extinct regions separately.
Scanning transmission electron microscopy (STEM)
We prepared the bone specimens for transmission electron microscopy (TEM) following standard methods. (52) The sections were dehydrated and embedded in Araldite® (Huntsman Advanced Materials Americas Inc., Los Angeles, California). Ultra-thin 70-80nm serial sections parallel to the Haversian canal direction were prepared with an MT-1 Ultra Microtome (DuPont Instruments-Sorval, Miami, Florida) using a diamond knife. We chose the width of the section, paralleling the Haversian canal direction, as the reference direction for the orientation of collagen. The specimens were placed on TEM grids.
Each TEM grid containing the specimens was placed on a STEM holder and examined using a Zeiss SUPRA VP-40 field emission scanning electron microscope (FESEM) equipped with a STEM detector at an accelerating voltage of 20 kV and at a working distance of 4 mm. The STEM rasters the focused incident probe across the specimen, which has been thinned to facilitate detection of electrons scattered through the specimen. The STEM detector enables pure bright field or extinct field imaging to achieve optimum contrasts and rich imaging details of unstained thin sections. Further, the transmission mode of the FESEM has the advantages of avoiding chromatic aberration, allowing for a larger aperture to obtain higher transmission, signal to noise ratio, and contrast enhancement due to the lower electron energy within the 10 to 30kV range. We observed and imaged the bone tissue at magnifications ranging between 6,000 and 54,000. We imported the images in XaraX software. We superimposed segments along the collagen bundles, and measured the magnitude of the smaller angle that the segment formed with the longitudinal reference line. The magnitude of the angle therefore varied between 0° and 90°.
Statistical analysis
We used statistical software package Stata (StataCorp LP, College Station, Texas) with the assistance of UCLA's Academic Technical Services Statistical Consulting Group. We expressed the data as mean ± standard error for all the measured parameters. The robustness of the morphometric method was analyzed through consideration of intra-and inter-observer errors relative to Haversian system area, whole osteon area, lamellar thickness, collagen length and collagen orientation, which involved manual marking to enable software detection for automatic measuring. To assess the magnitude of the intra-observer error, each parameter was measured on two specimens by one observer enough times (fifteen) to afford sufficient data to consider their distribution. The distributions did not show outliers or marked skewness. Therefore, the t-test was applied to compute the power of the mean to detect the actual measurements. Because we measured with a precision of 0.5%, the probability of the mean to provide the actual measurement ranged between 0.73 and 0.80. The error of not reflecting the actual measurement equals at most (max-min)/min, which was found between 0.005 and 0.007. The intra-observer error for a unique measurement was found to be less than 1%.
In the analysis of the inter-observer error between two independent observers measuring two specimens, the mean of the differences of corresponding measurements provided a power that ranged between 0.72 and 0.77 for the actual prediction of each measurement. The error of not reflecting the actual measurement equals at most (max-min)/min, between 0.006 and 0.008. The inter-observer error for a unique measurement on two specimens was found at most to be equal to 1%. On the basis of the 1% threshold of the above-analyzed morphometric errors, measurement by a single observer was considered appropriate.
After checking the normality of distributions, we used paired t-tests to establish significant differences between pre-and post-PTH(1-34) treatment for each of the input variables: average bright birefringence by CPL; percentage of whole osteons with specific birefringent pattern (bright, semi-homogeneous, alternate extinct); average thickness of each of bright and extinct lamellae; and percent areas at specific degree of calcification (initial, intermediate-low, intermediate-high, and final) before and after PTH(1-34) treatment. We computed, in degrees, the collagen angle with respect to the longitudinal direction from the SCM data with the basic trigonometric formula: (53) and compared these values with the experimental measurements of the same collagen angle obtained by STEM (Fig. 2) . The correlation between collagen angles computed from collagen length data and experimentally obtained collagen angles was evaluated by the coefficient r 2 . Because the two parameters of length of collagen bundles and collagen orientation within bright and extinct regions did not show a Gaussian distribution, we used the Kolmogorov-Smirnov test (54) to assess equality of distributions and non-parametric Chisquare statistics. For all the analyses, the level of significance was set at 0.05 before the Bonferroni adjustment for multiple comparisons.
Results

Collagen orientation underlying CPL birefringence by SCM and STEM
The bright and extinct birefringent signals of CPL were investigated by SCM and STEM, which allow the observation of the underlying distribution of collagen orientations. The length of the collagen bundles measured on SCM images ( Fig. 2A-3C ) within bright birefringent regions was statistically unchanged after PTH(1-34) treatment (0.28±0.01μm, 0.28±0.01μm; p=0.94). The length of the collagen bundles measured on SCM images within extinct birefringent regions was statistically unchanged after PTH(1-34) treatment (0.08±0.01μm vs. 0.07±0.01μm; p=0.38). The length of the collagen bundles differed between bright and extinct regions both before (bright, 0.22±0.02μm vs. extinct, 0.14±0.02μm, p=0.002), and after (bright, 0.21±0.02μm vs. extinct, 0.13±0.02μm, p=0.01), treatment, but there was no change due to the PTH(1-34) treatment itself.
We measured collagen orientation on STEM images of longitudinal sections prepared from regions that appear either birefringent bright or birefringent extinct in transverse section. The angle that collagen formed with the longitudinal direction on STEM images of longitudinal sections, within bright transverse regions (Figs. 2D-2G), clustered at 45°, with the majority (75±12% before and 73±9% after PTH(1-34) treatment, p=0.87) of the collagen bundles forming angles between 35° and 55°. The angle that the collagen bundles formed with the longitudinal direction within extinct transverse regions clustered at 10°, with the majority (82±10% before and 80±12% after PTH(1-34) treatment; p=0.39) of the collagen bundles forming angles between 0° and 23°. In particular, collagen orientation distribution differed significantly between bright and extinct birefringent regions both before (p=0.03), and after (p=0.04), PTH(1-34) treatment ( Figs. 2F and 2G ).
The collagen angles computed from the collagen length measured on SCM images correlated with the collagen angles measured on STEM images at bright regions (Figs. 2B, 2F, 2D) before (r 2 = 0.73), and after (r 2 =0.89), treatment with PTH(1-34) and at extinct regions (Figs. 2C, 2G, 2D) before (r 2 = 0.94), and after (r 2 = 0.98), treatment with PTH(1-34). Further, for bright regions, the computed collagen angles clustered at 45°, with the majority of the bundles forming angles between 35° and 55° (73±8% from SCM vs. 75±12% from STEM, p=0.63 before treatment; 83±7% from SCM vs. 73±9%, p=0.41 from STEM after treatment). For extinct regions, the computed collagen angles clustered at 10° with the majority (67±9% from SCM vs. 82±10% from STEM , p=0.22 before treatment; and 90±6% from SCM vs. 80±12% from STEM p=0.39, after treatment) of the collagen bundles forming angles between 0° and 23°.
RL and CPL microscopies
With PTH(1-34) treatment, the Harvesian system area changed from 11.92±5.82 to 12.76±4.50 (p=0.04) and the average brightness of CPL birefringence decreased from 0.45±0.02 to 0.40±0.01 (p=0.0005). Further, the number of whole osteons increased from 86.25±38.95 to 111.88 ±27. 34 Table 2 ). With PTH(1-34) treatment, the thickness of osteons' bright lamellae increased from 3.78±0.11μm to 4.47±0.14μm (p=0.0002); and the thickness of osteons' extinct lamellae increased from 3.32±0.12μm to 3.70±0.12μm (p=0.045) (Fig. 3 ). The number of lamellae per osteon was unchanged (10.41±2.89 vs. 10.51±2.90).
CPL miscroscopy and micro-X-radiograph
The comparison of percentages of alternate osteons at same degree of calcification before and after treatment show an increase at each stage of calcification that brings the total percentage of alternate osteons to the 75 to 80% range: specifically, from 19 
Discussion
We have evaluated cortical micro-structure, specifically the orientation of type I collagen and the degree of calcification, in biopsies from postmenopausal women with osteoporosis, before and after treatment with PTH(1-34). Our data confirm results on percent cortical porosity and degree of calcification obtained previously with different techniques. (25, 55) Specifically, the percent cortical porosity measured here by high-resolution micro-Xray was similar to that previously measured by microCT. (25) Further, our data using micro-X-ray showed that the percent area of osteons at initial stages of calcification was increased by PTH(1-34) treatment, confirming a previous result by quantitative backscattered electron imaging. (55) The techniques employed here for micro-structural investigation have been in development since the 1960s and have been applied mostly to basic science studies of human cortical bone. (42) The focus of the application in the current study has been the assessment of the variation of elementary components in iliac crest biopsies before and after treatment with PTH . In conformity with this line of investigation, the analysis was performed at increasing resolution to include variations within single osteons, and then within single lamella. We found a high degree of heterogeneity in Haversian system area, associated with a high degree of heterogeneity in number of osteons (r 2 =0.92), compatible with the high degree of heterogeneity in the cortical thickness response among the same patients. (25) With  PTH(1-34) treatment, the percentage increase in osteon ranges up to 116% with a mean±SE of 48.28±37.78. All patients had a similar response to treatment with respect to the other micro-structural parameters investigated: average brightness of CPL, osteon area, average percentage of alternate and non alternate osteons, lamellar thickness and distribution of degree of calcification.
We have analyzed the effect of PTH(1-34) on the orientation of collagen. At either bright or extinct birefringent regions, the lengths of collagen bundles obtained by SCM on the anterior-posterior/medial-lateral plane were reconciled with the assessment of the angles that collagen forms with the longitudinal direction by STEM (Fig. 2D ). This allowed us to compute and check the collagen orientation on two planes perpendicular to each other. The observed collagen orientations differed between bright and extinct birefringent regions, similar to previous results at the femoral mid-shaft. (41) Previous results have demonstrated that both collagen orientation and the degree of calcification independently affect the mechanical properties of bone. (42, (56) (57) (58) The results of this study are compatible with the previously reported difference between bright and extinct birefringent lamellae at the femoral shaft in terms of orientations of collagen bundles that locally parallel the carbonated hydroxyapatite crystals. The observed orientations suggested the bright lamellae to be less resistant to axial tension and bending than the extinct lamellae. (56) (57) (58) This hypothesis was supported by the presence of collagen orientation patterns in the shaft of long bones where longitudinal collagen is dominant in regions that undergo tension. Collagen forming larger angles with the longitudinal direction is dominant in regions that undergo compression due to bending during walking. (45) The brightness and extinction of birefringence are indicative of the dominance of collagen orientation with respect to the longitudinal direction. On transverse section, a higher average brightness means a greater percentage of collagen fibrils forming large angles with the osteon axis, whereas a lower average brightness represents a greater extent of collagen bundles that form smaller angles with the osteon axis. After PTH(1-34) treatment, the average brightness decreased, representing an increase in collagen bundles forming small angles with the longitudinal direction.
Possible explanations of this change in orientation in relation to the complex mechanical stimulation at the iliac crest include an improvement of tissue response to loading or simply an expression of increased heterogeneity of orientations. In fact, with PTH(1-34) treatment, larger regions of alternating bright and extinct lamellae replace regions of brightness in semi-homogeneous and in bright osteons compared to pre-treatment samples. Such change increases the variation of collagen orientation from location to location. Further, with PTH(1-34) treatment, the degree of calcification of osteons diversifies, with a higher number of osteons at initial degree of calcification relative to the rather homogeneous percentages of osteons at different degrees of calcification in the pre-PTH(1-34) treatment tissue. PTH(1-34) treatment brings the percentage of alternate osteons to the 75 to 80% range through percentage increases that are inversely proportional to the degree of calcification. PTH(1-34) treatment increases the proportion of osteons at initial stages of calcification, indicative of increased bone formation of osteons during remodeling, and reduce mean tissue age.
The lamellar thickness increase with PTH(1-34) treatment is a phenotype specific to the Haversian system. The lamellar thickness does not increase with PTH(1-34) treatment in either endocortical lamellae (3.58±0.64 vs. 3.71±0.72, p=0.14) or trabecular lamellae (3.45±0.76 vs.3.43±0.65; p=0.81). The increase in lamellar thickness observed with PTH(1-34) is unchanged by consideration of sub-grouping at specific stages of calcification (data not shown). Further, the lack of increase in lamellar number indicates that osteoblasts produce a standard number of lamellae. The lack of change in osteon surface area, compatible with the increase lamellar thickness and unchanged lamellar number because of the generally irregular osteon' s transverse section, leads us to hypothesize that the number of recruited osteoblasts that form an osteon is not affected by PTH(1-34) treatment. Because the number of osteons increases significantly with PTH(1-34) treatment and osteon size is unchanged, to increase cortical thickness, the balance of the increased number of osteons must form by remodeling of newly formed tissue. Therefore, the cortical tissue balance is modified by osteon number and, within the osteon, by lamellar thickness, and within endocortical bone, by lamellar number.
PTH(1-34) treatment has previously been found directly to stimulate bone formation without prior resorption on both endocortical and trabecular bone surfaces in postmenopausal women with osteoporosis. (59, 60) Lindsay et al. (61) suggested that bone formation occurs either on previously quiescent surfaces or by osteoblast spillover, from remodeling sites, to previously quiescent surfaces. Further, with PTH(1-34) treatment, the lamellar number increases in both trabeculae and endosteal lamellar packets, which, in conjunction with the absence of change in lamellar thickness, is responsible for the significant increase of the width of lamellar packets of trabecular and endocortical bone, respectively. (22, 25) Since the area occupied by the Haversian system increases substantially with PTH(1-34) treatment, we conjecture that new woven bone may form first, with perhaps primary osteons at the endosteal surface, rich in osteoblasts, before remodeling in terms of secondary osteons takes place. The fact that we do not observe either woven bone nor primary osteons leads us to hypothesize that the three-year duration of the treatment afforded time for the woven bone to be remodeled with secondary osteon.
The rate of osteon formation during remodeling was previously hypothesized to be associated with the thickness of birefringent bright lamellae on transverse sections of alternating osteons. (62) The rate of osteon formation was previously found to decrease from cement line to Haversian canal (63) . The thickness of lamellae may depend on the level of activity of osteoblasts during the interval of time while lamellae are formed, which is the time elapsing between the beginning of the osteoblasts' activity and the differentiation of osteoblasts into osteocytes. It is controversial whether lamellar thickness decreases from the cement line to the Haversian canal. (64, 65) Nevertheless, if indeed osteons' lamellar thickness depends on formation rate, then PTH(1-34) treatment would increase formation rate of osteons' lamellae. The rate of osteon formation during remodeling has not been measured and will be matter of future studies.
Collagen concentration may be lower in lamellae that appear extinct in transverse sections, regardless of age and of PTH(1-34) treatment. Such difference in concentration is more apparent in lamellae isolated from the surrounding osteon and observed in the original radial direction of the osteon. (41) Although we have not quantified such concentrations, other investigators have shown by scanning electron microscopy a difference in collagen concentration in the two types of lamellae, and coined the terminology "collagen rich" for the lamella that appears extinct on transverse section, and "collagen poor" or "collagen loose" for the lamella that appears bright on transverse section. (66) Because we find a lower average bright birefringence after treatment with PTH(1-34), the bone tissue may be richer in collagen in comparison to pre-treatment. Collagen-richer tissue may increase flexibility and delay fractures.
These observed micro-structural changes are initial steps in understanding the reduced fracture risk observed with PTH(1-34) treatment. (5, 9, 10) Indeed, our data indicate that PTH(1-34) treatment correlates with distribution of birefringence, and therefore distribution of collagen orientation, in osteons through arrangement and thickness of extinct and bright lamellae. (41) In particular, PTH(1-34) treatment may result in an increasing presence of alternate osteons with thicker bright and extinct lamellae. The percentage of alternate osteons and thickness of both bright and extinct lamellae increase from pre-to posttreatment. An increased lamellar thickness in cortical bone may help to reduce fracture risk at weight bearing sites. Prior studies have shown a reduction in lamellar thickness in osteons at the femoral neck of patients with femoral neck fracture, in contrast to patients without femoral neck fracture. (39) An increase in lamellar thickness may increase the osteon stiffness by reducing the extent of the weaker lamellar interface. (67) Other investigators have recently started to address heterogeneity of bone tissue in conjunction with the study of cortical tissue parameters at the site of atypical fractures in bisphosphonate-treated patients. In particular, Donnelly et al. have recently demonstrated the reduced compositional heterogeneity in bisphosphonate-treated bone. (68) It is also known that PTH treatment affects collagen cross-links. (69) (70) (71) It is possible that the reduced sensitivity of bone cells to detect mechanical stimulation in osteoporosis impedes the osteoblasts from producing a matrix with specific variations in terms of distributions of collagen orientation and degree of calcification, which would impair proper function and increase fracture risk. (72) The investigation of additional sub-micro-scale parameters that can affect fracture risk will be the subject of future studies.
This study is based on a small number of women, although the paired biopsy samples provide greater power than a cross sectional study. These women were all on long-term hormone/estrogen therapy when PTH(1-34) treatment was started. Whether this influenced our findings in cortical bone is unclear. Studies of the effect of PTH on cortical bone of women who have not been on prior or continued antiresorptive therapy are being planned in order to investigate this point.
The mechanism of the anabolic effect of PTH is complex. Animal studies indicate that PTH(1-34) treatment induces a rapid increase in osteoblast number without proliferation of progenitor cells. (73) PTH treatment increases cortical bone mass, cross-sectional area, and endocortical surfaces in rat cortical bone. (11) (12) (13) (14) Increased bone formation rate and mineralizing surface on the periosteal and endocortical surfaces have been found in rabbits. (15) Previous results on cortical bone show that the anabolic effect of PTH occurs primarily at the endocortical wall, (25) though periosteal apposition might also occur. (74) This study identifies elementary components of compact bone micro-structure as candidates to be checked for the reduction of fracture risk at weight bearing locations by PTH(1-34) treatment: both distribution of collagen orientation and degree of calcification are altered by PTH(1-34) treatment. These findings reinforce previous observations of collagen orientation and degree of calcification as optimally distributed in healthy bone tissue to withstand biomechanical demands, while pathological bone metabolism, such as that which occurs in postmenopausal women with osteoporosis, alters such distribution. (45, (75) (76) (77) (78) (79) (80) Values are reported as mean ± standard error. Cortical thickness and porosity were assessed by microCT in a previous study. (25) Measurements of bright and extinct birefringence and of micro-X-ray for cortices, osteons and lamellae.
Measurement
Type
Postmenopausal (n=8) p-value (paired t-test)
Pre-PTH
Post-PTH
Cortical birefringence (from 0 to 1) Values are reported as mean ± standard error. The number of the whole osteons varied between 37 and 150. There were between 6 to 15 lamellae per alternate osteon, meaning between 108 and 1485 lamellae per section.
